Meteora Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,868,200
Closed -$8.72M 195
2024
Q4
$8.72M Buy
+2,868,200
New +$12.5M 2.88% 9

Other funds holding RVNC